PME of Ohio, Inc. Notifies Customers of Data Security Incident
PME detected and took measures to address a security incident that involved unauthorized access to employee email accounts between
PME is offering a complimentary one-year membership for Experian's IdentityWorks credit monitoring and identify theft support. This product helps detect possible misuse of personal information and provides identity protection support. For more information on Experian's IdentityWorks, including instructions on how to activate the complimentary one-year membership, as well as some additional steps individuals may consider taking to protect their personal information, please visit PME's website and look for the link https://pmebabbittbearings.com/security-incident-notice/.
PME encourages everyone to remain vigilant by reviewing their account statements and credit reports for any unauthorized activity. If individuals see charges or activity they did not authorize, please contact the relevant credit bureau reporting the activity immediately.
We regret any inconvenience or concern this incident may cause. To help protect against an incident like this happening again, we implemented additional security measures to enhance the security of our email environment and will continue to train our employees concerning data security. If you believe your information was involved and/or have any questions about this incident please visit PME's website, https://pmebabbittbearings.com/security-incident-notice/ or by calling 833-918-7947, Monday through Friday, from
View original content:https://www.prnewswire.com/news-releases/pme-of-ohio-inc-notifies-customers-of-data-security-incident-302115643.html
SOURCE PME OF
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alfa Laval reinforces commitment to biofuels in new Brazilian biorefinery
- Team for the Planet launches a global call for innovation, awarding €1 million each to leading climate inventors
- Enhertu® Approved in the EU as First Tumor Agnostic HER2 Directed Therapy and Antibody Drug Conjugate for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share